HC Wainwright & Co.:重申Adicet Bio评级

证券之星
20 Dec 2024

HC Wainwright&Co.:重申adicet bio(ACET.US)评级,由中性调整至中性评级。艾切托(ACET.US)公司简介:Adicet Bio Inc是一家临床阶段的生物技术公司,发现和开发用于癌症和其他疾病的异体γδT细胞疗法。该公司的主要候选产品ADI-001是一种一流的异体γδT细胞疗法,表达靶向CD20的CAR,正在开发用于自身免疫性疾病和复发或难治性侵袭性B细胞非霍奇金...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10